SAN DIEGO, Nov. 4, 2019 /PRNewswire/ -- Agena Bioscience, a global provider of molecular testing solutions, today announced the release of the VeriDose™ CYP2D6 CNV panel designed to provide PGx ...
Cytochrome P450 2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6 (CYP2D6)) is involved in the phase I metabolism of approximately one-quarter of the most commonly prescribed medications, ...
Osimertinib in Patients With Epidermal Growth Factor Receptor Mutation–Positive Non–Small-Cell Lung Cancer and Leptomeningeal Metastases: The BLOOM Study The 6-month discontinuation rates of tamoxifen ...
(A) Transgene structures for the expression of the exogenous FLAG-tagged CYP2D6 protein or the IRES-based co-expression of the human hepatic CYP2D6 and GFP proteins. (B) Phase contrast images of the ...
We absolutely agree with the authors' statement that large, well-designed clinical trials would support genotype-guided tamoxifen administration. However, ideally one should adopt a genotyping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results